
Results
11
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
11 companies
PharmaResearch
Market Cap: ₩4.3t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩417,000.00
7D
8.5%
1Y
-37.7%
ST PharmLtd
Market Cap: ₩2.3t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩108,000.00
7D
7.2%
1Y
19.3%
Daewoong Pharmaceutical
Market Cap: ₩1.5t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩130,100.00
7D
5.3%
1Y
0.6%
Oscotec
Market Cap: ₩1.4t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩37,400.00
7D
8.1%
1Y
18.7%
Myung In Pharmaceutical
Market Cap: ₩723.4b
A pharmaceutical company, manufactures ETC and OTC drugs.
A317450
₩49,550.00
7D
14.3%
1Y
n/a
JW Holdings
Market Cap: ₩280.9b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩4,060.00
7D
6.8%
1Y
18.7%
Chong Kun Dang Holdings
Market Cap: ₩193.0b
Manufactures and distributes pharmaceutical products in South Korea and internationally.
A001630
₩40,550.00
7D
3.6%
1Y
-15.3%
Ilyang PharmaceuticalLtd
Market Cap: ₩161.1b
Operates as a pharmaceutical company primarily in South Korea.
A007570
₩8,990.00
7D
6.3%
1Y
-30.3%
Sinsin Pharmaceutical
Market Cap: ₩67.4b
Manufactures and sells pharmaceutical products in South Korea.
A002800
₩4,440.00
7D
4.0%
1Y
-20.9%
RP Bio
Market Cap: ₩55.7b
A bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally.
A314140
₩6,430.00
7D
3.9%
1Y
7.9%
Korean Drug
Market Cap: ₩38.2b
Manufactures and sells medicines for treating various diseases in South Korea.
A014570
₩3,505.00
7D
3.7%
1Y
-24.7%